行业动态报告 · 石油化工行业 油价重心回落,建议关注成长属性标的 8 月动态报告 2024年9月3日 核心观点 ● 8 月油价重心回落 供给端,8月1日 OPEC+会议结果显示维持此前产量政 策,将2023年4月宣布的166万桶/日的自愿减产措施延长至2025年底; 将 2023年 11月宣布的 220万桶/日的自愿减产措施延长至2024年9月底, 2024年10月至2025年9月期间将视市场情况逐步退出。此外,受不可抗 力因素影响,8月26日利比亚东部石油暂停生产和出口。需求端,月内美国 汽油库存持续下降,炼厂开工率保持在90%以上并逐步抬升。美国驾驶旺季 临近尾声,按照季节规律,9月中旬附近炼厂开工率面临下降压力,预计将 对原油需求施压。我们认为,在不出现极端供应中断意外的情况下,当前原 油市场供需预期偏弱,预计9月油价重心存下行压力,Brent 原油价格运行 区间参考 70-80 美元/桶。建议后续密切关注 OPEC+产量政策、美联储货币 政策、地缘局势演变等。8 月 Brent、WTI 月均价分别为 78.9、75.4 美元/ 桶,环比分别下降6.0%、6.4%。 | --- | --- | |-- ...

行业月报 · 传媒互联网行业 暑期新游表现亮眼,《黑神话：悟空》持续破圈 8 月行业月报 核心观点 ● 爆款影片数量少,暑期档票房同比下行。根据灯塔专业版数据,全国8月票 房 40.13 亿元(含服务费),同比下跌 48.09%,环比下跌 25.03%。需求 端,8月放映场次1293.8万场,同比上涨7.73%,环比下跌-0.99%;上座率 6.3%,同比下跌 50.39%,环比下跌 24.10%;观影人次 0.99亿,同比下跌 47.06%,环比下跌24.43%。8月上映影片数58部,影片数同环比分别上涨 26.09%,56.76%。目前已有38部垂点影片预计于9月上线,关注后续影片 上线表现。 ● 游戏行业供给稳中有增,重点新游表现亮眼:2024年前八个月版号发放数 量为 850 款，较去年同期的 610 款增长超 30%，游戏版号发放稳中有增，预 期行业供给端将持续向好。重点新游表现持续亮眼:《DNFm》、《三国:谋 定天下》、《绝区零》、《永劫无间手游》等均表现优异。随着后续新一批游 戏产品的陆续上线,预计游戏市场景气度有望持续保持。 ● 营销大盘稳中有进,细分渠道波动调整:根据 CTR发布的《202 ...

Investment Rating - The report maintains a "Recommend" rating for the company [6] Core Views - The company's profitability rebounded in Q2 2024, with a significant improvement in operating conditions compared to Q1 2024 [1] - Revenue growth is expected to turn positive starting from Q3 2024, driven by lower growth base, industry consolidation, and optimized competitive landscape [1] - The impact of credit impairment provisions on the company's performance is expected to gradually diminish [1] - The company is leveraging technological innovation and digital transformation to enhance efficiency and quality, with 92 new projects launched in H1 2024 and over 4,000 testing items available [2] Financial Performance - In H1 2024, the company reported revenue of RMB 3.881 billion (-9.92% YoY), net profit attributable to shareholders of RMB 90 million (-68.53% YoY), and operating cash flow of RMB 34 million (-90.31% YoY) [1] - In Q2 2024, revenue was RMB 2.040 billion (-6.91% YoY), with net profit attributable to shareholders of RMB 108 million (-19.92% YoY) and operating cash flow of RMB 173 million (+28.99% YoY) [1] - The company's gross margin in Q2 2024 improved to 37.17%, up 5.08 percentage points QoQ [1] - Excluding the impact of credit impairment provisions, the company's net operating profit margin in Q2 2024 was 11.84% [1] Technological Innovation and Digital Transformation - The company launched 92 new projects in H1 2024, covering key disease areas such as kidney, infection, neurology, hematology, and endocrinology [2] - The company has developed a medical testing industry large model application called "Xiao Yu Yi" and is actively exploring the construction of a medical testing data element infrastructure [2] - The company has automated access and cleaning of medical testing data, with a total volume exceeding 23PB, including over 12PB of gene sequencing results [2] Financial Forecasts - The report forecasts the company's revenue for 2024-2026 to be RMB 8.134 billion, RMB 9.293 billion, and RMB 10.503 billion, respectively [7] - Net profit attributable to shareholders is expected to be RMB 609.69 million, RMB 905 million, and RMB 1.209 billion for 2024-2026, respectively [7] - EPS for 2024-2026 is projected to be RMB 1.30, RMB 1.93, and RMB 2.58, respectively [7] - The current stock price corresponds to a PE ratio of 21x, 14x, and 10x for 2024-2026 [6]

Investment Rating - The report maintains a "Recommended" rating for the company [5]. Core Views - The company reported a significant increase in revenue and net profit for the first half of 2024, with operating income reaching 119 million yuan, a year-on-year growth of 32.63%, and a net profit attributable to shareholders of 13.97 million yuan, up 324.62% [3]. - The growth in revenue is attributed to increased demand in downstream markets, particularly in semiconductor equipment manufacturing, processing, and automotive products [3]. - The company's gross margin improved to 37.13%, and net margin reached 11.70%, reflecting successful market expansion and increased sales of high-margin products [3]. - The company is investing in harmonic reducers, aiming to create a second growth curve, with a planned investment of 250 million yuan for a production project [3]. Summary by Sections Financial Performance - In the first half of 2024, the company achieved operating income of 119 million yuan, a 32.63% increase year-on-year, and a net profit of 13.97 million yuan, a 324.62% increase [3]. - The weighted ROE for the first half of 2024 was 3.23%, with earnings per share of 0.08 yuan [3]. Market Expansion - The company has successfully expanded its market presence, leading to increased revenue from new customers and projects [3]. - The revenue contributions from processing, product sales, and other segments were 23 million yuan, 92 million yuan, and 4 million yuan, respectively, with year-on-year growth rates of 35.43%, 29.35%, and 129.15% [3]. Research and Development - The company allocated 5.78% of its operating income to R&D, continuing to enhance its innovation capabilities, and has recently obtained 7 new patents [3]. Future Outlook - Revenue projections for 2024-2026 are estimated at 251 million yuan, 289 million yuan, and 331 million yuan, with net profits of 42 million yuan, 48 million yuan, and 55 million yuan, respectively [4]. - The company is expected to benefit from favorable policies aimed at strengthening domestic supply chains, particularly in the industrial automation sector [3].

Industry Investment Rating - The report maintains a **"Recommend"** rating for the steel industry, indicating a positive outlook on the sector [1] Core Views - Steel prices are expected to stabilize in the short term, with a potential marginal improvement in profitability [1] - The steel industry index rose by **0.70%** during the week of August 25 to September 1, 2024, outperforming the broader market [5] - Over **60%** of the 36 listed steel companies reported profits in the first half of 2024 [9] Market Performance - The steel sector outperformed the Shanghai Composite Index, which fell by **0.43%**, while the Shenzhen Component Index and the ChiNext Index rose by **2.04%** and **2.17%**, respectively [5] - Among steel sub-sectors, **special steel** and **plate steel** showed the strongest performance, with gains of **1.18%** and **0.39%**, respectively [6] - **28 out of 45** steel-related stocks rose during the week, with the top performers being Xianglou New Materials, Erdos, and Guangda Special Materials, which gained **10.39%**, **6.81%**, and **6.20%**, respectively [7] Steel Price and Raw Material Analysis - Steel prices showed a slight upward trend, with domestic steel prices rising marginally [12] - Iron ore prices increased, with the Platts Iron Ore Index (62% Fe, CFR Qingdao) averaging **$101.1/ton**, up by **5.19%** week-over-week [14] - Domestic iron ore import prices rose to **683.0 yuan/ton**, a **4.75%** increase from the previous week [14] Inventory and Supply Trends - Social inventories of various steel products declined, with **rebar** inventories dropping by **8.00%** week-over-week to **442.9 thousand tons**, a **23.83%** decrease year-over-year [17] - **Hot-rolled coil** inventories fell by **1.08%** week-over-week to **346.2 thousand tons**, while **cold-rolled coil** inventories decreased by **1.20%** to **140.2 thousand tons** [17] - **Wire rod** and **medium plate** inventories also saw reductions of **3.66%** and **3.37%**, respectively [17] Profitability Analysis - Steel companies' profitability improved, with **rebar** margins rising by **158 yuan/ton** to **-240 yuan/ton**, and **wire rod** margins increasing by **152 yuan/ton** to **51 yuan/ton** [21] - **Medium plate** margins improved by **116 yuan/ton** to **-358 yuan/ton**, while **cold-rolled coil** and **hot-rolled coil** margins rose by **94 yuan/ton** and **105 yuan/ton**, respectively [21] Key Company Announcements - Several major steel companies released financial results, with some reporting significant revenue growth and improved profitability [25][26]

Investment Rating - The report maintains a "Recommended" rating for the company [3]. Core Insights - The company reported a revenue of 4.205 billion yuan in H1 2024, a decrease of 5.53% year-on-year, with a net loss attributable to shareholders of 216 million yuan compared to a profit of 10 million yuan in the same period last year [1]. - In Q2 2024, the company achieved a revenue of 2.404 billion yuan, reflecting a growth of 2.98% year-on-year, but the net profit attributable to shareholders decreased by 60.02% to 71 million yuan [1]. - The decline in H1 revenue was attributed to external factors affecting the inspection rhythm, while Q2 showed signs of recovery as the business is expected to perform better in the peak season of the health check industry in the second half of the year [1][2]. Summary by Sections Financial Performance - H1 2024 revenue was 4.205 billion yuan, down 5.53% year-on-year, with a net loss of 216 million yuan [1]. - Q2 2024 revenue was 2.404 billion yuan, up 2.98% year-on-year, with a net profit of 71 million yuan, down 60.02% [1]. Customer and Product Strategy - The average customer spending increased to 653 yuan in H1 2024, a growth of 9.93% from 594 yuan in the same period last year [1]. - The company is focusing on optimizing customer structure and developing innovative products to enhance customer spending [2]. Digital Transformation and Cost Efficiency - The company is enhancing digital technology in medical services to improve operational efficiency and reduce costs [2]. - Efforts include optimizing reagent usage and personnel scheduling through digital platforms, aiming for sustainable profit-oriented growth [2]. Future Outlook - The company anticipates a strong recovery in the health check industry, driven by quality improvements leading to price increases [2]. - Revenue forecasts for 2024-2026 are projected at 11.057 billion yuan, 12.302 billion yuan, and 13.619 billion yuan, with net profits of 523 million yuan, 885 million yuan, and 1.072 billion yuan respectively [2].

Investment Rating - The report maintains a "Recommended" rating for the company [4]. Core Views - The company reported a slight decline in revenue and net profit for the first half of 2024, with revenue at 910.37 billion yuan, down 0.34% year-on-year, and net profit at 28.39 billion yuan, down 3.63% year-on-year [1]. - The company experienced growth in its chemical engineering and new materials segments, with overseas performance showing significant improvement, particularly in new contract signings [1][2]. - The company is actively participating in the "Belt and Road" initiative, leading to substantial growth in overseas contracts, which increased by 132.53% year-on-year [1]. Financial Performance Summary - Revenue breakdown for H1 2024: Chemical engineering revenue was 739.18 billion yuan (up 4.32% YoY), infrastructure revenue was 101.24 billion yuan (down 20.23% YoY), environmental governance revenue was 11.24 billion yuan (down 22.39% YoY), and industrial and new materials revenue was 44.42 billion yuan (up 6.63% YoY) [1]. - The company achieved a gross margin of 9.39%, an increase of 1.05 percentage points year-on-year, while the net margin was 3.44%, a slight decrease of 0.07 percentage points [1]. - The company’s asset-liability ratio decreased to 69.83%, down 1.39 percentage points year-on-year, indicating improved financial stability [1]. Future Profitability Forecast - The company is projected to achieve net profits of 56.72 billion yuan, 61.86 billion yuan, and 68.25 billion yuan for the years 2024, 2025, and 2026, respectively, reflecting growth rates of 4.53%, 9.06%, and 10.33% [2][3]. - Corresponding P/E ratios are expected to be 7.04, 6.46, and 5.85 for the same years [2].

Investment Rating - The report maintains a "Buy" rating for the company [3] Core Views - The company reported a loss in H1 2024 but is expected to achieve profitability for the full year [1] - Passenger transport volume for domestic, international, and regional routes in H1 2024 reached 70.44 million, 8.02 million, and 0.9716 million respectively, representing 114.39%, 81.65%, and 71.20% of the 2019 levels [1] - Revenue for H1 2024 was 84.79 billion yuan, a year-on-year increase of 18.04%, and 116.25% of the 2019 level [1] - The company faced increased operating costs due to production recovery, with operating costs rising by 17.42% year-on-year [1] Financial Performance Summary - In H1 2024, the company achieved an operating revenue of 84.79 billion yuan, with a net profit attributable to shareholders of -1.228 billion yuan [1] - The operating costs for H1 2024 were 78.551 billion yuan, leading to a gross margin of 6.81% [1] - The company operated 907 aircraft as of the report date, maintaining its position as the largest airline in Asia [2] - The forecast for earnings per share (EPS) for 2024, 2025, and 2026 is 0.03 yuan, 0.22 yuan, and 0.37 yuan respectively, with corresponding price-to-earnings (PE) ratios of 167.89X, 24.72X, and 15.08X [2][8]

Investment Rating - The report maintains a "Buy" rating for the company [3] Core Views - The company recorded a passenger transport volume of 65.16 million domestic, 7.54 million international, and 2.26 million regional passengers in H1 2024, representing 144.79%, 87.86%, and 77.94% of the same period in 2019 respectively [1] - The company's revenue for H1 2024 reached 79.52 billion yuan, a year-on-year increase of 33.39%, and 103.61% of the revenue in the same period of 2019 [1] - The operating cost for H1 2024 was 77.47 billion yuan, up 30.84% year-on-year, with a gross margin of 2.58%, which is still below the 15.31% gross margin of 2019 [1] Financial Performance - The company is expected to achieve basic earnings per share of 0.04, 0.30, and 0.41 yuan for the years 2024, 2025, and 2026 respectively, with corresponding PE ratios of 190.25X, 22.95X, and 16.48X [2][8] - The company operated a total of 915 aircraft as of June 30, 2024, with a fleet structure that continues to optimize [2] - The report forecasts total revenue of 165.54 billion yuan for 2024, with a revenue growth rate of 17.32% [8][10]

行业周报 · 钢铁行业 ፱期钢价小幅回升，盈利能力有望边际改善 2024年09月02日 一周钢铁板块指数上涨,特钢、板材等相关标的表现较好。本周上证指数 跌幅为 0.43%;深证成指涨幅为 2.04%;创业板指数涨幅为 2.17%;一级行 业指数中,钢铁板块涨幅为 0.70%。根据我们对于钢铁行业公司划分子板块数 据,本周特钢和板材涨幅较大,分别为1.18%、0.39%。钢铁板块个股中,上 涨、维持和下跌的个股占比分别为62.22%,11.11%和26.67%。 ● 本周钢材价格小幅向上,钢厂去库效果显著。本周国内钢材市场价格小幅 上涨。截止8月30日,螺纹钢均价为 3324.6元/吨,较上周上涨 86.6元/吨, 涨幅 2.67%;本周线材均价 3243.8 元/吨,较上周上涨 60.8 元/吨, 涨幅为 1.91%。本周热轧板均价为 3315.6元/吨,较上周上涨 64.2 元/吨,涨幅为 1.97%;本周大中型材均价为 3534.8元/吨,较上周上涨 28.4元/吨,涨幅为 0.81%。本周焊管均价为3670.6元/吨,较上周下跌27.0元/吨,跌幅为0.73%; 无缝管均价 4446.4元/吨,较上周 ...